PHILADELPHIA, March 1, 2011 /PRNewswire/ -- ERT (Nasdaq: ERES),
a global technology-driven provider of clinical services and
customizable medical devices to bio-pharmaceutical and healthcare
organizations, announced today that the Nasdaq Stock Market has
approved a change in the Company's trading symbol. ERT will
trade on the Nasdaq Global Select Market under the symbol "ERT"
effective March 7, 2011.
Stockholders are advised to make note of this trading symbol
change.
"ERT has evolved as a strong brand under which we operate, and
this change to our trading symbol is intended to properly align our
business brand with the investment community," said Joel Morganroth, Chief Executive Officer of
ERT.
For further information on ERT and its technology and services,
please email info@ert.com, call +1 215 972 0420 or visit
www.ert.com.
For further press information, please contact Fiona Robinson, The Scott Partnership,
One Whiteside, Station Road, Holmes
Chapel, Cheshire CW4 8AA, United
Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, email
ert@scottpr.co.uk.
About ERT
ERT (www.ert.com) is a global technology-driven provider of
clinical services and customizable medical devices to
biopharmaceutical and healthcare organizations. It is
the market leader for centralized cardiac safety and
respiratory efficacy services in drug development and also
collects, analyzes and distributes electronic Patient Reported
Outcomes (ePRO) in multiple modalities across all phases of
clinical research.
|
Media
Contacts:
|
|
|
|
Fiona Robinson
|
John Blakeley
|
|
|
The Scott
Partnership
|
ERT
|
|
|
Tel: +44 1477
539539
|
+1 215 972 0420
|
|
|
ert@scottpr.com
|
jblakeley@ert.com
|
|
|
|
SOURCE ERT